These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30843073)

  • 21. High-throughput selected reaction monitoring liquid chromatography-mass spectrometry determination of methylphenidate and its major metabolite, ritalinic acid, in rat plasma employing monolithic columns.
    Barbarin N; Mawhinney DB; Black R; Henion J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):73-83. PubMed ID: 12450526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPLC determination of methylphenidate and its metabolite, ritalinic acid, by high-performance liquid chromatography with peroxyoxalate chemiluminescence detection.
    Wada M; Abe K; Ikeda R; Kikura-Hanajiri R; Kuroda N; Nakashima K
    Anal Bioanal Chem; 2011 Apr; 400(2):387-93. PubMed ID: 21318251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of perinatal methylphenidate (MPH) treatment in male and female Sprague-Dawley offspring.
    Panos JJ; Law CD; Ferguson SA
    Neurotoxicol Teratol; 2014; 42():9-16. PubMed ID: 24444667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-methylphenidate and D,L-methylphenidate are not developmental toxicants in rats and rabbits.
    Teo SK; Stirling DI; Hoberman AM; Christian MS; Thomas SD; Khetani VD
    Birth Defects Res B Dev Reprod Toxicol; 2003 Apr; 68(2):162-71. PubMed ID: 12866707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro.
    Bartl J; Palazzesi F; Parrinello M; Hommers L; Riederer P; Walitza S; Grünblatt E
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):281-288. PubMed ID: 28690202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L- and D-threo ethylphenidate concentrations, pharmacokinetics, and pharmacodynamics in horses.
    Knych HK; McKemie DS; Seminoff K; Hartmann P; Hovda L; Benson D
    Drug Test Anal; 2018 Oct; 10(10):1508-1517. PubMed ID: 29786965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal exposure to methylphenidate affects the dopamine system and the reactivity to natural reward in adulthood in rats.
    Lepelletier FX; Tauber C; Nicolas C; Solinas M; Castelnau P; Belzung C; Emond P; Cortese S; Faraone SV; Chalon S; Galineau L
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [LC-MS/MS assay of methylphenidate: stability and pharmacokinetics in human].
    Luo XM; Ding L; Gu X; Jiang LY; Dong X
    Yao Xue Xue Bao; 2014 Jan; 49(1):83-8. PubMed ID: 24783511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid quantitative analysis of methylphenidate and ritalinic acid in oral fluid by liquid chromatography triple quadrupole mass spectrometry (LC-QqQ-MS).
    Mulet CT; Arroyo-Mora LE; Leon LA; Gnagy E; DeCaprio AP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():313-319. PubMed ID: 29935479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of the enantiomers of threo-methylphenidate.
    Patrick KS; Caldwell RW; Ferris RM; Breese GR
    J Pharmacol Exp Ther; 1987 Apr; 241(1):152-8. PubMed ID: 3572779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in plasma concentrations of the D- and L-threo methylphenidate enantiomers in responding and non-responding children with attention-deficit hyperactivity disorder.
    Jonkman LM; Verbaten MN; de Boer D; Maes RA; Buitelaar JK; Kemner C; van Engeland H; Koelega HS
    Psychiatry Res; 1998 Mar; 78(1-2):115-8. PubMed ID: 9579707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A post hoc analysis of d-threo-methylphenidate hydrochloride (focalin) versus d,l-threo-methylphenidate hydrochloride (ritalin).
    Weiss M; Wasdell M; Patin J
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1415-21. PubMed ID: 15502601
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Quansah E; Ruiz-Rodado V; Grootveld M; Probert F; Zetterström TSC
    Neurochem Int; 2017 Sep; 108():109-120. PubMed ID: 28268188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject.
    Marchei E; Farrè M; Pellegrini M; García-Algar O; Vall O; Pacifici R; Pichini S
    Forensic Sci Int; 2010 Mar; 196(1-3):59-63. PubMed ID: 20096514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol.
    Markowitz JS; DeVane CL; Boulton DW; Nahas Z; Risch SC; Diamond F; Patrick KS
    Drug Metab Dispos; 2000 Jun; 28(6):620-4. PubMed ID: 10820132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enantioselective determination of methylphenidate and ritalinic acid in whole blood from forensic cases using automated solid-phase extraction and liquid chromatography-tandem mass spectrometry.
    Thomsen R; Rasmussen HB; Linnet K;
    J Anal Toxicol; 2012 Oct; 36(8):560-8. PubMed ID: 22833645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicokinetic assessment of methylphenidate (Ritalin(R)) in a 13-week oral (gavage) toxicity study in rats using an enantiomeric liquid chromatography/tandem mass spectrometry assay.
    Bakhtiar R; Tse FL
    Rapid Commun Mass Spectrom; 2003; 17(18):2160-2. PubMed ID: 12955748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.